Jodid Hexal (Potassium Iodide)

Jodid Hexal (potassium iodide) is used within the iodine‑related therapeutic area to address several clinical needs.

• Iodine deficiency prevention: restores adequate iodine levels in populations at risk of deficiency.
• Radioprotection of the thyroid: reduces uptake of radioactive iodine during nuclear incidents or medical procedures.
• Adjunct in thyroid hormone synthesis disorders: provides iodide substrate to facilitate production of T3 and T4 in patients with certain synthesis impairments.

• Potassium iodide dissociates to release iodide ions, which are actively taken up by the thyroid gland via the sodium‑iodide symporter. The iodide becomes incorporated into the synthesis of thyroid hormones triiodothyronine (T3) and thyroxine (T4). In the presence of radioactive iodine, excess stable iodide competitively inhibits its uptake, thereby protecting thyroid tissue from radiation exposure.

Potassium iodide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Metallic or salty taste in the mouth.
• Nausea or mild vomiting.
• Abdominal discomfort or cramping.
• Mild headache.
• Transient skin rash.

Serious or Rare Side Effects

• Hypersensitivity reactions, including anaphylaxis.
• Iodide‑induced hyperthyroidism or thyrotoxicosis.
• Severe thyroid dysfunction requiring medical intervention.
• Pulmonary edema (rare).
• Stevens‑Johnson syndrome or other severe cutaneous adverse reactions.

When prescribing or dispensing Jodid Hexal, consider the following safety measures.

• Assess iodine status: evaluate baseline iodine levels before initiating therapy.
• Monitor thyroid function: perform periodic TSH and hormone assessments during treatment.
• Avoid in known iodine allergy: contraindicated for patients with hypersensitivity to iodide.
• Use with caution in pregnancy or lactation: weigh potential benefits against fetal or infant risks.
• Review concomitant medications: consider possible interactions with thyroid‑active drugs.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Potassium iodide can influence the activity of several other agents.

Major Interactions (Avoid)

• Radioactive iodine therapy: reduces therapeutic efficacy of administered radioiodine.
• Levothyroxine or other thyroid hormone replacements: may alter dosing requirements.
• Thiazide diuretics: can increase iodide retention and risk of hyperthyroidism.

Moderate Interactions (Monitor Closely)

• Antacids containing aluminum or magnesium: may decrease iodide absorption.
• ACE inhibitors: potential for altered renal handling of iodide.
• Amiodarone: additive iodine load may affect thyroid status.